Integrin
All Product Categories
-
Integrin Inhibitors
(183)
View all products
-
Integrin Agonists
(5)
View all products
-
Integrin Antagonists
(68)
View all products
-
Integrin Activators
(7)
View all products
-
Integrin Modulators
(5)
View all products
-
Integrin Chemicals
(2)
View all products
-
Integrin Inducers
(2)
View all products
-
Integrin Degrader
(1)
View all products
-
Integrin Controls
(3)
View all products
-
Integrin Substrate
(1)
View all products
-
Integrin Ligands
(15)
View all products
-
Integrin Related Products (382)
Related Products (382)
-
NPC-15669
0 ImagesCat. No.: HY-112079CAS No.: 132684-62-9NPC-15669 is a novel Mac-1 inhibitor. NPC-15669 reduces plasma levels of ET-1, TxB, prostacyclin, AT-III, and total protein S. NPC-15669 can be used in the research of myocardial infarction.
-
RGD-DA6
0 ImagesCat. No.: HY-176300CAS No.: 3105965-82-7RGD-DA6 is an αvβ3-targeted ligand. RGD-DA6 consists of RGDfK (an integrin αvβ3-targeted RGD peptide), DOTADG, d-Glu, Lys, AMBA, and IPBA. RGD-DA6 can be radiolabeled as an αvβ3-targeted radioligand and used for high-contrast tumor imaging and enhanced anticancer efficacy.
-
Tris-ανβ6 integrin ligand-3
0 ImagesCat. No.: HY-185469CAS No.: 3047235-33-3
-
GR144053 trihydrochloride
0 ImagesCat. No.: HY-107590CAS No.: 1215333-48-4GR 144053 trihydrochloride is a selective and non-peptic GPIIb/IIIa inhibitor (IC50=37 nM).
-
Lotrafiban
0 ImagesCat. No.: HY-10314CAS No.: 171049-14-2Synonyms: SB-214857Lotrafiban is an orally-active platelet GPIIb/IIIa blocker for research of coronary and cerebrovascular disease.
-
MSH-TP15e
0 ImagesCat. No.: HY-P991250MSH-TP15e is a humanized monoclonal antibody inhibitor targeting intercellular adhesion molecule-1 (ICAM-1). MSH-TP15e recruits natural killer cells and significantly triggers antibody-dependent cell-mediated cytotoxicity (ADCC) to inhibit tumor cell growth. MSH-TP15e is promising for research of multiple myeloma (MM).
-
RGDSPASSKP
0 ImagesCat. No.: HY-P2635CAS No.: 91575-25-6RGDSPASSKP is a RGDS-containing fibronectin decapeptide.
-
PA-IIL
0 ImagesCat. No.: HY-NP216Synonyms: LecBPA-IIL (LecB) is a lectin produced by Pseudomonas aeruginosa. PA-IIL binds to glycosylated β1-integrin, fucose-containing glycosphingolipids, fucosylated/mannosylated neutrophil glycoconjugates, and pre-formed neutrophil extracellular traps. PA-IIL disrupts host defenses: it creates favorable conditions for Pseudomonas aeruginosa infection and dissemination by modulating the bactericidal activity of neutrophils, impairing the trafficking and recruitment of immune cells, and compromising the repair capacity of epithelial barriers. PA-IIL can be used in studies related to Pseudomonas aeruginosa infection.
-
G-Pen-GRGDSPCA
0 ImagesCat. No.: HY-P3525CAS No.: 126716-28-7G-Pen-GRGDSPCA is an αvβ3-inhibiting RGD peptide. G-Pen-GRGDSPCA can limit neointimal hyperplasia and lumen stenosis after vascular injury, as well as regulate the migration and proliferation of smooth muscle cells. G-Pen-GRGDSPCA can be used in the study of the mechanism of vascular injury repair.
-
Hydroxyflutamide (Standard)
0 ImagesCat. No.: HY-W013272RCAS No.: 52806-53-8Synonyms: HFT (Standard)Hydroxyflutamide (Standard) (HFT (Standard)) is the analytical standard of Hydroxyflutamide (HY-W013272). This product is intended for research and analytical applications. Hydroxyflutamide (HFT) is the active metabolite of Flutamide (HY-B0022) and exhibits oral activity. Hydroxyflutamide is a potent androgen receptor antagonist with an IC50 of 700 nM. Hydroxyflutamide can affect embryonic development and reproductive tract development in mice. Additionally, Hydroxyflutamide can enhance the efficacy of Bacillus Calmette-Guérin (BCG) to better inhibit the progression of bladder cancer. Hydroxyflutamide can be used in research related to tumors and reproductive diseases.
-
Rondaptivon pegol sodium scrambled negative control
0 ImagesCat. No.: HY-153999CRondaptivon pegol sodium scrambled negative control is the sequence scrambled negative control of Rondaptivon pegol sodium.
-
L-734217
0 ImagesCat. No.: HY-106932CAS No.: 146144-48-1L-734217 is an orally active and potent fibrinogen receptor antagonist and an antithrombotic agent. L-734217 is excreted largely by the renal route and partly into the bile in dogs. L-734217 is promising for research of thrombotic disorders.
-
Anti-Fibronectin III Antibody
0 ImagesCat. No.: HY-P992228
-
Elarofiban diTFA
0 ImagesCat. No.: HY-10315ACAS No.: 198958-89-3Elarofiban diTFA is the salt form of Elarofiban (HY-10315) with two TFA. Elarofiban diTFA is a nonpeptide, orally active antagonist for fibrinogen receptor αIIbβ3 (GPIIb/IIIa), with an IC50 of 0.15 nM. Elarofiban diTFA has the potential for platelet mediated thrombotic disorders research.
-
Eptifibatide acetate (Standard)
0 ImagesCat. No.: HY-B0686BRCAS No.: 881997-86-0Eptifibatide (acetate) (Standard) is the analytical standard of Eptifibatide (acetate). This product is intended for research and analytical applications. Eptifibatide acetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity.
-
ASP5094
0 ImagesCat. No.: HY-P991603ASP5094 is a humanized monoclonal antibody against integrin alpha-9. ASP5094 has good safety and tolerability. ASP5094 can be used in the research of diseases such as rheumatoid arthritis.
-
G-{d-Arg}-GDSP
0 ImagesCat. No.: HY-P3530CAS No.: 111844-21-4G-{d-Arg}-GDSP is an RGD peptide analogue that binds to the adhesion receptor of integrins and inhibits cellular fibronectin attachment as well as osteoclast resorption.
-
Tris-ανβ6 integrin ligand-2
0 ImagesCat. No.: HY-185468CAS No.: 3047235-30-0
-
Anti-Mouse CD11a Antibody (I21/7)
0 ImagesCat. No.: HY-P991812Anti-Mouse CD11a Antibody (I21/7) reacts with the mouse CD11a. CD11a functions in the immune system. CD11a is involved in cellular adhesion and costimulatory signaling. Recommend Isotype Controls: Rat IgG2a kappa, Isotype Control (HY-P990679).
-
Anti-ICAM3/CD50 Antibody
0 ImagesCat. No.: HY-P990436The Anti-ICAM3/CD50 Antibody is a human antibody expressed in CHO, targeting ICAM3/CD50. The Anti-ICAM3/CD50 Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. For isotype control of the Anti-ICAM3/CD50 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
